Quarterly report pursuant to Section 13 or 15(d)

Significant Customers (Details Narrative)

v3.21.1
Significant Customers (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues, net $ 15,271 $ 1,888
Sales Revenue, Net [Member] | Diagnostic Services Clients One [Member]    
Concentration risk, percentage 46.10%  
Sales Revenue, Net [Member] | Diagnostic Services Clients Two [Member]    
Concentration risk, percentage 31.60%  
Sales Revenue, Net [Member] | Third Party Contract Manufacturing Customer One [Member]    
Concentration risk, percentage   48.60%
Sales Revenue, Net [Member] | Third Party Contract Manufacturing Customer Two [Member]    
Concentration risk, percentage   18.00%
Sales Revenue, Net [Member] | Third Party Contract Manufacturing Customer Three [Member]    
Concentration risk, percentage   17.30%
Trade Receivable [Member] | Diagnostic Services Clients One [Member]    
Concentration risk, percentage 64.00%  
Trade Receivable [Member] | Diagnostic Services Clients Two [Member]    
Concentration risk, percentage 25.00%  
Trade Receivable [Member] | Customer One [Member]    
Concentration risk, percentage   49.00%
Trade Receivable [Member] | Customer Two [Member]    
Concentration risk, percentage   18.00%
Trade Receivable [Member] | Customer Three [Member]    
Concentration risk, percentage   12.00%
Trade Receivable [Member] | Customer Four [Member]    
Concentration risk, percentage   11.00%